The American Ophthalmological Society (AOS), founded in 1864, is the oldest American specialty society that has functioned without interruption into the 21st century. In order to maintain a tradition of excellence, presentations should be on timely topics, and authors should give scrupulous attention to both content and form.
SELECTION OF TOPIC
Appropriate topics for a presentation include clinical, applied, or basic research; observational and population-based studies; medical services research; bioethics position papers; laboratory biomedical research; innovative surgical techniques; administrative issues; and other investigations that advance the science and art of ophthalmology. Reviews or opinion pieces without data are not appropriate. The presentation should be original and not previously published elsewhere (see Submission of Presentation to a Journal below), and the quality of the work should be equivalent to that of a first-ratepeer-reviewed journal article.
USE OF A BIOSTATISTIAN
For presentations requiring statistical analyses, the use of a biostatistician or epidemiologist prior to undertaking the project can avoid later problems. The methodology, end points, and planned analysis should ideally be determined prior to collection of data.
STRUCTURE OF THE PRESENTATION
The presentation should include a review of background material, detailed methodology, and presentation of results and discussion. Conclusions should be formulated. In general, case reports are not acceptable, but case series may be included.
All persons designated as authors should qualify for authorship and should be listed in the order of their participation in the presentation. One of the authors must be an AOS member, but the AOS member does not need to be the presenter. The AOS member must be present during the presentation and discussion at the Annual Meeting. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. One or more authors should take responsibility for the integrity of the work as a whole, from inception to presentation. It is appropriate to have the same authors and acknowledgments if the paper is published. Increasingly, authorship of multicenter trials is attributed to a group. All members of the group who are named as authors should fully meet the above criteria for authorship.
A structured abstract of no more than 300 words is required and is the only content published in the Transactions of the AOS. Use the following format:
State the major objective of the study.
Describe the design of the study, noting randomization, masking, criteria standards, and temporal direction (retrospective or prospective) as applicable. Indicate the study setting (e.g., institutional, multicenter, primary care, referral practice). Identify the patients or other participants by noting selection procedures, entry criteria, and numbers. Specify the intervention procedures and the main outcome measures.
Briefly summarize the principal results obtained. Results should be accompanied by data with confidence intervals and the exact level of statistical significance. Results should also identify any significant limitations or qualifications of the data and give suitable emphasis to positive and negative findings.
State the conclusions directly supported by the data, describe the clinical or research applications, compare to the prior literature, and indicate limitations of the study.At the time the Abstract is submitted for consideration of presentation by the Committee on Program at the Annual Meeting, the author must attest to appropriate IRB approval of the study, must declare all financial disclosures, and must indicate if off-label use will be contained in the presentation.
THE PRESENTATION AT THE AOS MEETING
Your podium presentation must be in PowerPoint, Keynote, or Prezi format, and must be uploaded to the media management system prior to the meeting. Presenters are NOT permitted to use their own laptop computers. Detailed instructions will be sent to each presenter. Changes to your presentation can be made onsite by visiting the audiovisual technician at least 4 hours prior to your presentation time. Embedded videos may be used, and should be prepared and tested ahead of time. Your presentation time will not be extended because of technical difficulties originating from the presenter. You will be provided a comfort display monitor in front of the podium.
The AOS follows ACCME disclosure guidelines. The first slide of your presentation must provide ALL financial disclosures relevant to your presentation related to ANY commercial ophthalmic company over the previous twelve (12) months. You should also indicate verbally that these involvements relate to your presentation. A financial disclosure template is available should you need one. When you submit your slides to the media management system prior to the meeting, the audiovisual technician will check for this slide. If a disclosure slide is not present, you will not be allowed to present until one has been inserted as your first slide. You should pause on this slide and comment on the content. The same slide should indicate whether you will discuss off-label usage.
Presentation times are strictly enforced, and a timer is provided on the podium. The microphone may be turned off, and the discussant invited to the podium at that time. After the discussion, the presenter is asked to respond to the comments. This wrap-up is strictly limited to one (1) minute and is not an opportunity to present new content. Additionally, the authors are reminded to seek objectivity, use best available evidence, avoid using commercial slides, and be aware that the learners in their evaluations of this activity will be asked if commercial bias was present.
CONTENT THE DISCUSSANT NEEDS TO RECEIVE
Your presentation will be discussed by a member of the Society and then opened for general discussion to participants at the meeting. In fairness, the Discussant must receive your complete presentation at least six (6) weeks prior to the meeting, including your slides, talking points, and preferably a copy of your planned wording. You will receive the email address of the Discussant to transmit these documents. If you fail to provide adequate and timely content to the Discussant, the presenter risks removal of your presentation from the program. A copy of the content sent to the Discussant should also be sent to the current Program Chair.
PUBLICATION IN THE TRANSACTIONS
Only the Abstract of the presentation will be published in the Transactions, which is published on the AOS website during the same year as accepted.
SUBMISSION OF THE PRESENTATION TO A JOURNAL
The authors are encouraged to offer their presentation as a manuscript for a peer-reviewed journal. Submission of your presentation to a journal should include the following footnote: “This manuscript is based on a presentation at the Annual Meeting of the American Ophthalmological Society in <year>.
If there are any changes to your abstract since your original submission, the final abstract should be received in digital format at the AOS meeting, and no later than the day of the presentation, by the AOS office, which will be forwarded to the Editor of the Transactions.